Refine by
Hiv Aids Treatment Suppliers & Manufacturers
5 companies found
based inMoscow, RUSSIA
NANOLEK is a modern, fast-growing Russian biopharmaceutical company, specializing in the production of import-substituting and innovative drugs. Our high-tech full-cycle production facilities fully comply with GMP and ISO standards. Our portfolio ...
Disease-modifying drug for the treatment of HIV; a second-generation protease inhibitor forming part of standard first-line treatments of ...
based inNanjing, CHINA
Founded in 2013, Frontier Biotechnologies Inc. (“Frontier Biotech”) is a commercial-stage biopharmaceutical company headquartered in China with global vision and world-class competitiveness. Frontier Biotech is committed to discovering, development, ...
Aikening ® is a long-acting HIV fusion inhibitor for the treatment of HIV infection and AIDS. Aikening ® represents multiple technological breakthroughs in the aspects of ...
based inCambridge, MASSACHUSETTS (USA)
Abt Associates is an engine for social impact, harnessing the power of data and grounded insight to move people from vulnerability to security worldwide.We do more than solve the challenges our clients have today. We collaborate to solve the ...
based inFoster City, CALIFORNIA (USA)
Gilead is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. At Gilead, we’re committed to creating possible. For more than 30 years, we’ve pursued the ...
Bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg. Worsening of hepatitis B virus (HBV) infection. Your healthcare provider will test you for HBV infection before or when you start treatment with BIKTARVY. If you have HBV infection ...
based inNorth Ryde, AUSTRALIA
Biotron Limited (Biotron) is a clinical stage publicly listed Australian Biotechnology Company based in Sydney, Australia. The company is developing and commercialising a novel small molecule approach that has the potential to treat a number of ...
Biotron is developing novel small molecule antiviral therapeutics targeting a range of viruses including Hepatitis C virus (HCV) and ...